CN103007237B - Medicine for treating idiopathic thrombocytopenic purpura (ITP) - Google Patents
Medicine for treating idiopathic thrombocytopenic purpura (ITP) Download PDFInfo
- Publication number
- CN103007237B CN103007237B CN201210595364XA CN201210595364A CN103007237B CN 103007237 B CN103007237 B CN 103007237B CN 201210595364X A CN201210595364X A CN 201210595364XA CN 201210595364 A CN201210595364 A CN 201210595364A CN 103007237 B CN103007237 B CN 103007237B
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- root
- itp
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating idiopathic thrombocytopenic purpura (ITP), aiming to screen natural Chinese herbal medicine components to enable the natural Chinese herbal medicine components to come into play according to the knowledge of pathogenesis of ITP in the traditional Chinese medicine and treatment rules of ITP. The medicine is prepared from the following components: 75g of cassia twig, 4g of asarum, 15g of prepared common monkshood branched root, 50g of fresh ginger, 75g of kelp, 10g of almonds, 150g of Chinese dates, 60g of turmeric root tuber, 50g of turmeric, 12g of saffron, 16g of ginkgo leaves, 18g of lightyellow sophora root, 15g of peony root, 10g of common hogfenneI root, 12g of calamus, 6g of storax, 30g of heartleaf houttuynia herb and 10g of white mulberry root-bark, wherein the medicines are ground into fine powder and are taken after being mixed with boiling water.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to the medicine for the treatment of idiopathic thrombocytopenic purpura, Chinese patent medicine prepared as raw material by the Chinese herbal medicine of take specifically.
The background technology idiopathic thrombocytopenic purpura is the platelet autoimmune destruction, thrombocytopenic hemorrhage in peripheral blood.With extensive skin, mucosa or visceral hemorrhage, thrombocytopenia, cause skin petechia ecchymosis, mucosa and visceral hemorrhage, severe patient can cause intracranial hemorrhage and threat to life, it is a kind of disease of serious harm health, at present this disease of western medical treatment be take hormone (as glucocorticoid) as main, but the side effect of hormone is huge, can bring other serious complication (as occurred the disease such as hypoadrenocorticism after the hormone of stopping using) to human body.This disease belongs to motherland's medical science " blood disorder " category, and Chinese medicine is huge potentiality tool for aspect this disease for the treatment of, and the medicine that therefore idiopathic thrombocytopenic purpura is treated in invention is treated this disease.
Summary of the invention the purpose of this invention is to provide the medicine for the treatment of idiopathic thrombocytopenic purpura, to overcome the deficiencies in the prior art.
The objective of the invention is pathogenetic understanding and Therapeutic Principle thereof to idiopathic thrombocytopenic purpura according to motherland's medical tradition medical science, with reference to modern pharmacological research, therefrom filter out this sick natural Chinese medicinal herb for the treatment of, by the theory of Chinese medical science prescription, it is played a role.
Medicine of the present invention is made by following component:
Ramulus Cinnamomi 75 gram Herba Asari 4 gram Radix Aconiti Lateralis Preparata 15 gram Rhizoma Zingiberis Recens 50 gram Thallus Laminariae (Thallus Eckloniae) 75 gram Semen Armeniacae Amarum 10 gram Fructus Jujubae 150 gram Radix Curcumae 60 gram Rhizoma Curcumae Longae 50 gram Stigma Croci 12 gram Folium Ginkgo 16 gram Radix Sophorae Flavescentis 18 gram Radix Paeoniae Rubra 15 gram Radix Peucedani 10 gram Rhizoma Acori Graminei 12 gram Styrax 6 gram Herba Houttuyniae 30 gram Cortex Mori 10 grams
Above-mentioned each component mix homogeneously is ground into to 180 order fine powders, is distributed into bag, every packed medicated powder 9 grams.One after each meal, one bag of every day, use warm boiled water at twice.
Medicine of the present invention is Chinese medicine preparation, theoretical according to traditional Chinese medical science formula, select medicine rationally, treating both the principal and secondary aspects of a disease.Medicine of the present invention, through clinical observation patient for many years, evident in efficacy, the idiopathic thromboeytopenic purpura idiopathic thromboeytopenic purpura people that a variety of causes is caused has remarkable result.
Clinical drug of the present invention is taken result and is shown, following advantage is arranged:
It is raw material that the present invention selects natural plant, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment idiopathic thrombocytopenic purpura of the medicine of respectively distinguishing the flavor of, without chemicals, nontoxic to human body, has no side effect, safe and reliable.The present invention is powder, and effective ingredient scatters and disappears few, and curative effect is high, cheap, and taking convenience, without any discomfort disease.
For showing the therapeutic effect of medicine of the present invention to idiopathic thrombocytopenic purpura, the present invention is through the clinical observation of 540 routine idiopathic thrombocytopenic purpura patient systems, and select medical history, the state of an illness, age to reach the idiopathic thrombocytopenic purpura Patients with 300 Cases suitable with traditional therapy group as a comparison, age 16-62 year, course of disease 1-6; Test group: the conventional medicine of stopping using, take medicine of the present invention; Matched group: take conventional medicine.Observation period is 3 months, after half a year, checks, and without recurrence, for produce effects, the state of an illness is clearly better as effectively, and it is not obvious that sb.'s illness took a favorable turn is invalid.
Clinical experiment the results are shown in Table 1.
Table 1: take medicine of the present invention and the observation of curative effect to idiopathic thrombocytopenic purpura with traditional Western medicine.
Two groups of effective percentage of table 1 relatively
Annotate: curative effect relatively adopts statistical method, and enumeration data adopts X
2Check, two groups of effective percentage compare P<0.01
As can be seen from Table 1, two groups of effective percentage relatively: the experimental group total effective rate is 96.3%, and matched group is 40.6%, and experimental group obviously is better than matched group (P<0.01), illustrates that medication effect of the present invention significantly is better than traditional Western medicine.
The specific embodiment
Choose raw material by following proportioning:
Ramulus Cinnamomi 75 gram Herba Asari 4 gram Radix Aconiti Lateralis Preparata 15 gram Rhizoma Zingiberis Recens 50 gram Thallus Laminariae (Thallus Eckloniae) 75 gram Semen Armeniacae Amarum 10 gram Fructus Jujubae 150 gram Radix Curcumae 60 gram Rhizoma Curcumae Longae 50 gram Stigma Croci 12 gram Folium Ginkgo 16 gram Radix Sophorae Flavescentis 18 gram Radix Paeoniae Rubra 15 gram Radix Peucedani 10 gram Rhizoma Acori Graminei 12 gram Styrax 6 gram Herba Houttuyniae 30 gram Cortex Mori 10 grams
Above-mentioned each component mix homogeneously is ground into to 180 order fine powders, is distributed into bag, every packed medicated powder 9 grams.One after each meal, one bag of every day, use warm boiled water at twice.
Claims (1)
1. the medicine for the treatment of idiopathic thrombocytopenic purpura, is characterized in that the powder of being made by the raw material of following weight proportioning: Ramulus Cinnamomi 75 grams, Herba Asari 4 grams, Radix Aconiti Lateralis Preparata 15 grams, Rhizoma Zingiberis Recens 50 grams, Thallus Laminariae (Thallus Eckloniae) 75 grams, Semen Armeniacae Amarum 10 grams, Fructus Jujubae 150 grams, Radix Curcumae 60 grams, Rhizoma Curcumae Longae 50 grams, Stigma Croci 12 grams, Folium Ginkgo 16 grams, Radix Sophorae Flavescentis 18 grams, Radix Paeoniae Rubra 15 grams, Radix Peucedani 10 grams, Rhizoma Acori Graminei 12 grams, Styrax 6 grams, Herba Houttuyniae 30 grams, Cortex Mori 10 grams; Above-mentioned each component mix homogeneously is ground into to 180 order fine powders and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210595364XA CN103007237B (en) | 2012-12-10 | 2012-12-10 | Medicine for treating idiopathic thrombocytopenic purpura (ITP) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210595364XA CN103007237B (en) | 2012-12-10 | 2012-12-10 | Medicine for treating idiopathic thrombocytopenic purpura (ITP) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103007237A CN103007237A (en) | 2013-04-03 |
| CN103007237B true CN103007237B (en) | 2013-12-04 |
Family
ID=47956701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210595364XA Expired - Fee Related CN103007237B (en) | 2012-12-10 | 2012-12-10 | Medicine for treating idiopathic thrombocytopenic purpura (ITP) |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103007237B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106214750A (en) * | 2016-08-31 | 2016-12-14 | 青岛大学附属医院 | A kind of medicine for external use treating body surface internal hemorrhage |
| CN106176948A (en) * | 2016-08-31 | 2016-12-07 | 高艳 | A kind of light-duty chronic purpura method for preparing externally applied of child |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101115493A (en) * | 2005-08-12 | 2008-01-30 | 河乃建仁 | Agent for hair growth |
-
2012
- 2012-12-10 CN CN201210595364XA patent/CN103007237B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101115493A (en) * | 2005-08-12 | 2008-01-30 | 河乃建仁 | Agent for hair growth |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103007237A (en) | 2013-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007237B (en) | Medicine for treating idiopathic thrombocytopenic purpura (ITP) | |
| CN102357240A (en) | Traditional Chinese medicine for treating peripheral vascular functional disease of Raynaud disease | |
| CN102526613B (en) | Medicament for treating allergic cutaneous vasculitis | |
| CN104800799B (en) | It is a kind of to treat Chinese medicine of the endometrial thickness with ovarian cyst | |
| CN102973803A (en) | Drug for treating hematopathy primary thrombocytopenic purpura | |
| CN102526622B (en) | Medicine for treating knee-joint bursitis | |
| CN102824460A (en) | Medicine for treating urticaria | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN103070992B (en) | Medicine for treating high myopia macular hemorrhages | |
| CN102512589B (en) | Medicine for treating early sudden deafness | |
| CN102552569B (en) | Medicine for treating renal artery type arteritis | |
| CN103301261A (en) | Medicine for treating transplant kidney main renal venous stenosis | |
| CN103690675A (en) | Traditional Chinese medicine composition detoxicating pills with effects of clearing away heat and toxic materials and improving immunity | |
| CN102406875A (en) | Drug for treating endometriosis interna | |
| CN103230484B (en) | Drug for treating knee osteoarthritis of patients under age of 40 | |
| CN103990101A (en) | Traditional Chinese medicine composition for treating gynecological disease | |
| CN102648975A (en) | Traditional Chinese medicine for treating primary thrombocytopenic purpura | |
| CN102908598B (en) | Medicine for treating children fungal pneumonia | |
| CN102512546B (en) | Traditional Chinese medicine used for esophageal cancer patients refusing surgery | |
| CN102526610A (en) | Traditional Chinese medicine for curing multiple takayasu arteritis | |
| CN102406775A (en) | Traditional Chinese medicine capable of terminating early pregnancy | |
| CN102512637B (en) | Medicine for treating special chronic sinusitis of patients | |
| CN102363021A (en) | Chinese medicine for treating cervical disc retrogression | |
| CN102430095A (en) | Medicine for treating lung cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131204 Termination date: 20141210 |
|
| EXPY | Termination of patent right or utility model |